CERO THERAPEUTICS HOLDINGS, INC. |
Director |
Warrant to Purchase Shares of Common Stock |
306K |
$600K |
$1.96 |
Feb 7, 2025 |
Direct |
CERO THERAPEUTICS HOLDINGS, INC. |
Director |
Warrant to Purchase Shares of Common Stock |
204K |
$400K |
$1.96 |
Feb 7, 2025 |
By GVN, LLC |
CERO THERAPEUTICS HOLDINGS, INC. |
Director |
Common Stock |
491K |
$49.00 |
$0.00 |
Mar 31, 2025 |
Indirect |
CERO THERAPEUTICS HOLDINGS, INC. |
Director |
Pre-Funded Warrant |
204K |
$20.00 |
$0.00 |
Mar 31, 2025 |
By GVN, LLC |
CERO THERAPEUTICS HOLDINGS, INC. |
Director |
Pre-Funded Warrant |
11.7K |
$1.00 |
$0.00 |
Mar 31, 2025 |
Direct |
CERO THERAPEUTICS HOLDINGS, INC. |
Director |
Common Stock |
1.25K |
$0 |
$0.00 |
Mar 31, 2025 |
Direct |
CERO THERAPEUTICS HOLDINGS, INC. |
Director |
Series A Convertible Preferred Stock |
0 |
$0 |
$1,000.00 |
Sep 25, 2024 |
Atwood-Edminster Trust dtd 4-2-2000 |
Clovis Oncology, Inc. |
Director |
Stock Option (right to buy) |
42.2K |
|
|
Jun 10, 2021 |
Direct |
CERO THERAPEUTICS HOLDINGS, INC. |
Director |
Stock Option (Right to Buy) |
14.9K |
|
|
Mar 4, 2025 |
Direct |
Atreca, Inc. |
Director |
Stock Option (right to buy) |
12K |
|
|
Jun 13, 2023 |
Direct |